FOR IMMEDIATE RELEASE
American Indian Cancer Foundation, BeastRob, Colon Cancer Alliance for Research and Education for Lynch Syndrome, New York Oncology Hematology, United Digestive, and Veridata Health join a national effort built around measurable benchmarks for colorectal cancer screening, diagnosis, and treatment
[Springfield, Missouri] Fight Colorectal Cancer (Fight CRC) announced that six organizations have endorsed its Colorectal Cancer Care Initiative (CRCCI), bringing community, hereditary cancer, clinical, and data perspectives to a national effort to raise the standard of colorectal cancer care.
“Each new endorser is putting its name behind a clear, measurable standard for colorectal cancer care, and that matters,” said Joya Delgado Harris, Director of CRCCI at Fight Colorectal Cancer. “As community advocates, hereditary cancer experts, GI and oncology practices, and health data companies join the Initiative, we are building a clearer picture of where patients are being missed and who is positioned to reach them.”
American Indian Cancer Foundation (AICAF) is a national, Native-governed nonprofit working to eliminate the cancer burdens faced by American Indian and Alaska Native people by improving access to prevention, early detection, treatment, and survivor support.
BeastRob is a nonprofit organization committed to changing how communities talk about and respond to colorectal cancer. It was founded in honor of Robert “Beast” Vinson, who was diagnosed with stage IV rectal cancer at age 49, on the belief that no family should face colorectal cancer without the knowledge, resources, and support they need. Through honest conversations, community education, advocacy, and efforts to improve access to screening, BeastRob meets people where they are and encourages them to take an active role in their health.
Colon Cancer Alliance for Research and Education for Lynch Syndrome (CCARE-Lynch Syndrome) is a national nonprofit dedicated to raising awareness of Lynch syndrome among health care professionals and the public, and to supporting research. Because Lynch syndrome is the most common hereditary cause of colorectal cancer, CCARE-Lynch Syndrome’s work aligns closely with CRCCI’s goal of ensuring patients receive germline genetic testing at diagnosis.
New York Oncology Hematology (NYOH) is an independent, physician-owned community oncology practice that has cared for patients across New York’s Capital Region for more than 30 years, with locations in Albany, Amsterdam, Clifton Park, Hudson, and Troy. NYOH brings a frontline clinical perspective to the Initiative’s diagnosis and treatment goals.
United Digestive is an Atlanta-based gastroenterology practice management organization that partners with independent GI practices across the Southeast. With gastroenterology practices at the center of screening and follow-up colonoscopy, United Digestive connects CRCCI’s screening benchmarks directly to the point of care.
Veridata Health builds the grid for precision medicine: software that closes the loop between laboratory data, AI models, and clinical teams, so every result leads to a reviewed next step. As a health data company, Veridata brings a data perspective to the Initiative and reflects the growing role data plays in understanding where patients fall out of the care pathway.
CRCCI includes endorsing organizations across health systems, physician practices, pharmaceutical and diagnostics companies, nonprofit and patient advocacy groups, and medical associations. Endorsers are united around two CRCCI goals with measurable targets. Goal 1 focuses on timely screening for prevention and early detection, aiming for an 80% screening rate among average-risk patients and ensuring 80% of patients with an abnormal non-invasive test receive follow-up colonoscopy within 90 days. Goal 2 focuses on accurate diagnosis and timely treatment initiation, with targets of 80% of colorectal cancer patients receiving biomarker testing per NCCN Guidelines®, 80% receiving germline genetic testing at diagnosis, and 80% initiating treatment within six weeks of diagnosis.
To learn more about CRCCI or to inquire about becoming an endorsing organization, visit fightcolorectalcancer.org or contact Joya Delgado Harris at joya@fightcrc.org.
About Fight Colorectal Cancer
Fight CRC is the leading colorectal cancer advocacy organization offering patient support, screening guidance, research updates, and ways to take action against colon and rectal cancer.
About the Colorectal Cancer Care Initiative
The CRCCI is a national Initiative of patient advocates, physicians, public health champions and healthcare leaders uniting around data-driven goals to transform colorectal cancer (CRC) screening, diagnosis, and treatment. Learn how your organization can join the Initiative and advance our shared mission: Colorectal Cancer Care Initiative – Fight Colorectal Cancer
Media Contact:
Name: Joya Delgado Harris
Email: joya@fightcrc.org